✦ LIBER ✦

Prevalence of resistance mutations related to integrase inhibitor S/GSK1349572 in HIV-1 subtype B raltegravir-naive and -treated patients

✍ Scribed by Malet, I.; Wirden, M.; Fourati, S.; Armenia, D.; Masquelier, B.; Fabeni, L.; Sayon, S.; Katlama, C.; Perno, C. F.; Calvez, V.; Marcelin, A.-G.; Ceccherini-Silberstein, F.

Book ID: 118003059
Publisher: Oxford University Press
Year: 2011
Tongue: English
Weight: 99 KB
Volume: 66
Category: Article
ISSN: 0305-7453
DOI: 10.1093/jac/dkr152

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prevalence of HIV-1 integrase mutations

Prevalence of HIV-1 integrase mutations related to resistance to dolutegravir in raltegravir naïve and pretreated patients

✍ F. Saladini; G. Meini; C. Bianco; L. Monno; G. Punzi; M. Pecorari; V. Borghi; M. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 39 KB

Resistance associated mutations to dolut

Resistance associated mutations to dolutegravir (S/GSK1349572) in HIV-infected patients – Impact of HIV subtypes and prior raltegravir experience

✍ Carolina Garrido; Vincent Soriano; Anna Maria Geretti; Natalia Zahonero; Silvia 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Prevalence of mutations related to HIV-1

Prevalence of mutations related to HIV-1 antiretroviral resistance in Brazilian patients failing HAART

✍ Amilcar Tanuri; Elena Caridea; Maria C. Dantas; Marisa G. Morgado; Daise L.C. Me 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 121 KB

Drug resistance mutations and newly reco

Drug resistance mutations and newly recognized treatment-related substitutions in the HIV-1 protease gene: Prevalence and associations with drug exposure and real or virtual phenotypic resistance to protease inhibitors in two clinical cohorts of antiretroviral experienced patients

✍ Carlo Torti; Eugenia Quiros-Roldan; Laura Monno; Andrea Patroni; Annalisa Saraci 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 1 views

## Abstract This study aimed at identifying HIV‐1 protease amino acid changes associated with protease inhibitor (PI) exposure and susceptibility. New amino acid substitutions were correlated with the number of experienced PIs, reaching statistical significance only for those at positions 3, 44, an